Middle East Regulatory Policy Brief

Covering Pharmacovigilance, Labelling, Packaging Defect, Ministerio para la Transición Ecológica y el Reto Demográfico, State Water Resources Control Board. Key regulatory updates covering Pharmacovigilance, Labelling, and Packaging Defect in Saudi Arabia, alongside insights on Ministerio para la Transición Ecológica y el Reto Demográfico and State Water Resources Control Board sectors.

Show Notes

This episode of Carver's Middle East Regulatory Updates delves into critical topics such as Pharmacovigilance, Labelling, and Packaging Defects impacting the pharmaceutical sector, with additional focus on regulatory frameworks involving the Ministerio para la Transición Ecológica y el Reto Demográfico and the State Water Resources Control Board.

The Saudi Food and Drug Authority (SFDA) has issued a notification concerning a packaging defect affecting batch number 010524 of the pharmaceutical product ألفاكالسيدول. The defect centers on missing Arabic and English labeling on the packaging, prompting the SFDA to provide an English package leaflet as a corrective measure. Healthcare professionals are advised to review this leaflet thoroughly and counsel patients accordingly to prevent misuse.

This update underscores the importance of accurate labelling and patient information in safeguarding public health and maintaining regulatory compliance within the pharmacovigilance domain.

For more information, visit the Carver Agents website.

Articles mentioned:
  1. ألفاكالسيدول

What is Middle East Regulatory Policy Brief?

Regulatory news, updates, and insights for countries in the Middle East presented by the Carver Agents team

Welcome to Carver's Middle East Regulatory Updates.

The Saudi Food and Drug Authority has issued a notification regarding a packaging defect affecting batch number 010524 of the pharmaceutical product ألفاكالسيدول. The defect involves missing Arabic and English labeling on the packaging. As a corrective action, the authority has provided an English package leaflet to accompany the affected batch.

Healthcare professionals in Saudi Arabia are advised to carefully review the English package leaflet before dispensing this batch. They must also ensure that patients receive appropriate counseling about the correct use of the product. The Saudi Food and Drug Authority emphasizes exercising caution when handling this batch to prevent misuse or medication errors, thereby safeguarding patient safety and maintaining regulatory compliance.

That wraps up today's regulatory updates. Visit carveragents.ai for more information.